RAFFA WEALTH MANAGEMENT, LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76K Buy
6
+1
+20% +$284 ﹤0.01% 870
2026
Q1
$1.39K Hold
5
﹤0.01% 855
2025
Q4
$1.51K Hold
5
﹤0.01% 814
2025
Q3
$1.4K Sell
5
-30
-86% -$8.16K ﹤0.01% 811
2025
Q2
$8.45K Buy
35
+30
+600% +$7.09K ﹤0.01% 410
2025
Q1
$1.22K Hold
5
﹤0.01% 773
2024
Q4
$1.64K Hold
5
﹤0.01% 723
2024
Q3
$1.67K Hold
5
﹤0.01% 685
2024
Q2
$1.37K Hold
5
﹤0.01% 812
2024
Q1
$1.73K Hold
5
﹤0.01% 743
2023
Q4
$1.61K Hold
5
﹤0.01% 685
2023
Q3
$1.79K Hold
5
﹤0.01% 618
2023
Q2
$1.9K Hold
5
﹤0.01% 621
2023
Q1
$2.4K Hold
5
﹤0.01% 557
2022
Q4
$2.1K Hold
5
﹤0.01% 574
2022
Q3
$2.09K Hold
5
﹤0.01% 586
2022
Q2
$2.48K Hold
5
﹤0.01% 553
2022
Q1
$2.82K Hold
5
﹤0.01% 546
2021
Q4
$3.78K Hold
5
﹤0.01% 497
2021
Q3
$3.73K Hold
5
﹤0.01% 451
2021
Q2
$3.22K Hold
5
﹤0.01% 490
2021
Q1
$2.86K Buy
5
+1
+25% +$592 ﹤0.01% 539
2020
Q4
$2.33K Hold
4
﹤0.01% 517
2020
Q3
$2.06K Hold
4
﹤0.01% 489
2020
Q2
$1.81K Hold
4
﹤0.01% 498
2020
Q1
$1.4K Hold
4
﹤0.01% 498
2019
Q4
$1.48K Hold
4
﹤0.01% 477
2019
Q3
$1.33K Buy
+4
New +$1.3K ﹤0.01% 494
2019
Q2
Sell
-4
Closed -$1.22K 815
2019
Q1
$1.22K Hold
4
﹤0.01% 487
2018
Q4
$929 Hold
4
﹤0.01% 566
2018
Q3
$1.25K Hold
4
﹤0.01% 508
2018
Q2
$1.15K Hold
4
﹤0.01% 517
2018
Q1
$1K Buy
+4
New +$1.02K ﹤0.01% 552

Other funds holding BIO

RAFFA WEALTH MANAGEMENT, LLC's BIO Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Bio-Rad Laboratories Class A (BIO) stake by 20% in Q2 2026, buying an estimated $284 and bringing the position to 6 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in BIO in Q1 2018 and has held it in 33 quarters since. The position peaked at $8.45K in Q2 2025. 93 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 6 shares of Bio-Rad Laboratories Class A worth $1.76K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #870 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and has held it in 33 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Bio-Rad Laboratories Class A position peaked at $8.45K in Q2 2025.
  • 93 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.